Published in Wound Repair Regen on November 21, 2007
Beta-glucans in the treatment of diabetes and associated cardiovascular risks. Vasc Health Risk Manag (2008) 1.06
Protective effects of beta glucan and gliclazide on brain tissue and sciatic nerve of diabetic rats induced by streptozosin. Exp Diabetes Res (2012) 0.90
Macrophage stimulating agent soluble yeast β-1,3/1,6-glucan as a topical treatment of diabetic foot and leg ulcers: A randomized, double blind, placebo-controlled phase II study. J Diabetes Investig (2013) 0.80
Effects of purified Saccharomyces cerevisiae (1→3)-β-glucan on venous ulcer healing. Int J Mol Sci (2012) 0.80
No Association between Glycemia and Wound Healing in an Experimental db/db Mouse Model. ISRN Endocrinol (2013) 0.79
Effect of temperature and diet on wound healing in Atlantic salmon (Salmo salar L.). Fish Physiol Biochem (2015) 0.75
Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 5.46
Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 4.38
Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Clin Cancer Res (2008) 2.37
Estimated GFR associates with cardiovascular risk factors independently of measured GFR. J Am Soc Nephrol (2011) 2.25
Limitations of hemoglobin A1c for the diagnosis of posttransplant diabetes mellitus. Transplantation (2015) 2.00
[What does the Tidsskriftet's editorial committee do?]. Tidsskr Nor Laegeforen (2009) 1.93
Association of albuminuria and cancer incidence. J Am Soc Nephrol (2008) 1.91
Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation. Transplantation (2009) 1.79
Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovasc Diabetol (2009) 1.62
The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer. J Thorac Oncol (2011) 1.49
Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients. Nephrol Dial Transplant (2004) 1.46
Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation. Nephrol Dial Transplant (2014) 1.45
The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer. J Thorac Oncol (2011) 1.43
The impact of short-term ciclosporin A treatment on insulin secretion and insulin sensitivity in man. Nephrol Dial Transplant (2007) 1.43
Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survival. Cancer (2010) 1.42
Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer. Clin Cancer Res (2007) 1.41
Diagnosing PTDM. Transplantation (2002) 1.37
Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study. Nephrol Dial Transplant (2008) 1.30
The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma. Histopathology (2009) 1.28
Albuminuria as risk factor for initiation and progression of carotid atherosclerosis in non-diabetic persons: the Tromsø Study. Eur Heart J (2006) 1.27
Prognostic impact of MiR-155 in non-small cell lung cancer evaluated by in situ hybridization. J Transl Med (2011) 1.27
Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survival. Cancer (2011) 1.24
Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells. J Thorac Oncol (2008) 1.16
Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. J Am Soc Nephrol (2004) 1.13
Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose. Eur J Endocrinol (2009) 1.13
MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer. PLoS One (2012) 1.07
Prognostic impact of lymphocytes in soft tissue sarcomas. PLoS One (2011) 1.06
Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: coexpression with VEGFR-3 and PDGF-B predicts poor survival. J Thorac Oncol (2009) 1.03
Disturbances in beta-cell function in impaired fasting glycemia. Diabetes (2002) 1.01
A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients. Nephrol Dial Transplant (2003) 1.01
Diverse prognostic roles of Akt isoforms, PTEN and PI3K in tumor epithelial cells and stromal compartment in non-small cell lung cancer. Anticancer Res (2009) 1.01
Undiagnosed diabetes in kidney transplant candidates: a case-finding strategy. Clin J Am Soc Nephrol (2010) 1.01
The prognostic impact of TGF-β1, fascin, NF-κB and PKC-ζ expression in soft tissue sarcomas. PLoS One (2011) 0.99
Albuminuria and risk of nonvertebral fractures. Arch Intern Med (2007) 0.99
Ewing sarcoma-peripheral neuroectodermal tumor of the kidney with a FUS-ERG fusion transcript. Cancer Genet Cytogenet (2009) 0.98
Diverging prognostic impacts of hypoxic markers according to NSCLC histology. Lung Cancer (2010) 0.97
Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Tromsø Study. BMC Cardiovasc Disord (2013) 0.97
[Boycott of academic cooperation with China]. Tidsskr Nor Laegeforen (2013) 0.96
Cancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced. Radiat Oncol (2012) 0.96
Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha/CXCL1. J Biol Chem (2010) 0.96
Stress and immunity: minireview. Folia Biol (Krakow) (2002) 0.96
Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients. J Am Soc Nephrol (2006) 0.95
Prognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2. PLoS One (2011) 0.95
Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis. PLoS One (2010) 0.94
Glycated hemoglobin level is strongly related to the prevalence of carotid artery plaques with high echogenicity in nondiabetic individuals: the Tromsø study. Circulation (2004) 0.94
Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage. Nephrol Dial Transplant (2005) 0.92
Disease-specific outcomes of radical prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time. BMC Urol (2014) 0.92
Reduced incidence of new-onset posttransplantation diabetes mellitus during the last decade. Transplantation (2007) 0.92
Physical exercise, fasting glucose, and renal hyperfiltration in the general population: the Renal Iohexol Clearance Survey in Tromsø 6 (RENIS-T6). Clin J Am Soc Nephrol (2012) 0.91
Overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survival. PLoS One (2011) 0.91
Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas. PLoS One (2012) 0.90
Overexpression of matrix metalloproteinase-7 and -9 in NSCLC tumor and stromal cells: correlation with a favorable clinical outcome. Lung Cancer (2011) 0.90
Fasting plasma glucose in the screening for type 2 diabetes in morbidly obese subjects. Obes Surg (2009) 0.90
Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancer. J Thorac Dis (2012) 0.89
Early versus late acute antibody-mediated rejection in renal transplant recipients. Transplantation (2013) 0.89
Stage and tissue-specific prognostic impact of miR-182 in NSCLC. BMC Cancer (2014) 0.88
Estrogen receptor and progesterone receptor are prognostic factors in soft tissue sarcomas. Int J Oncol (2011) 0.88
The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas. J Transl Med (2011) 0.88
Infiltration of CD8+ lymphocytes is an independent prognostic factor of biochemical failure-free survival in prostate cancer. Prostate (2014) 0.88
The VEGF- and PDGF-family of angiogenic markers have prognostic impact in soft tissue sarcomas arising in the extremities and trunk. BMC Clin Pathol (2014) 0.87
Diabetes: cost of illness in Norway. BMC Endocr Disord (2010) 0.87
The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation. Clin Transplant (2002) 0.87
Estimated GFR is biased by non-traditional cardiovascular risk factors. Am J Nephrol (2015) 0.87
Hypoadiponectinemia is associated with insulin resistance and glucose intolerance after renal transplantation: impact of immunosuppressive and antihypertensive drug therapy. Clin J Am Soc Nephrol (2006) 0.86
Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes. Inflammation (2002) 0.86
Angiogenic markers show high prognostic impact on survival in marginally operable non-small cell lung cancer patients treated with adjuvant radiotherapy. J Thorac Oncol (2009) 0.86
Determinants of short-term changes in body composition following renal transplantation. Scand J Urol Nephrol (2009) 0.86
CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy. Lung Cancer (2013) 0.86
COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67. Cancer Epidemiol (2010) 0.86
Quantitative measurement of muscle fiber composition in a normal population. Muscle Nerve (2003) 0.85
Immunohistochemical expression of epithelial and stromal immunomodulatory signalling molecules is a prognostic indicator in breast cancer. BMC Res Notes (2012) 0.85
Spontaneously formed tumorigenic hybrids of Meth A sarcoma cells and macrophages in vivo. Int J Cancer (2003) 0.85
Changes in the Secretory Profile of NSCLC-Associated Fibroblasts after Ablative Radiotherapy: Potential Impact on Angiogenesis and Tumor Growth. Transl Oncol (2013) 0.85
Determinants of insulin secretion after renal transplantation. Metabolism (2003) 0.85
From inflammation to sickness: historical perspective. Arch Immunol Ther Exp (Warsz) (2003) 0.85
The prognostic value of intraepithelial and stromal CD3-, CD117- and CD138-positive cells in non-small cell lung carcinoma. APMIS (2010) 0.84
Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas. BMC Clin Pathol (2012) 0.84
VEGF-A and VEGFR-3 correlate with nodal status in operable non-small cell lung cancer: inverse correlation between expression in tumor and stromal cells. Lung Cancer (2008) 0.84
Clinical significance of epidermal growth factor receptors in non-small cell lung cancer and a prognostic role for HER2 gene copy number in female patients. J Thorac Oncol (2010) 0.84
New-onset posttransplantation diabetes mellitus: insulin resistance or insulinopenia? Impact of immunosuppressive drugs, cytomegalovirus and hepatitis C virus infection. Curr Diabetes Rev (2005) 0.84
Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients. J Transl Med (2011) 0.83
In NSCLC, VEGF-A response to hypoxia may differ between squamous cell and adenocarcinoma histology. Anticancer Res (2012) 0.83
The role of TFPI in regulation of TF-induced thrombogenicity on the surface of human monocytes. Thromb Res (2010) 0.83
Spontaneously formed tumorigenic hybrids of Meth A sarcoma and macrophages grow faster and are better vascularized than the parental tumor. Int J Cancer (2002) 0.83
Glucose tolerance before and after renal transplantation. Nephrol Dial Transplant (2009) 0.82
Anthropometric characteristics and type 2 diabetes in extremely obese Caucasian subjects: a cross-sectional study. Diabetes Res Clin Pract (2009) 0.82
A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears. Cancer Cytopathol (2013) 0.82
Correlation and coexpression of HIFs and NOTCH markers in NSCLC. Anticancer Res (2011) 0.82
Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas. BMC Clin Pathol (2013) 0.82
Prognostic impacts of hypoxic markers in soft tissue sarcoma. Sarcoma (2012) 0.82
Early posttransplantation hyperglycemia in kidney transplant recipients is associated with overall long-term graft losses. Transplantation (2012) 0.82
Autoregulation of endogenous glucose production during hyperglucagonemia. Metabolism (2002) 0.82
Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients. Transplantation (2006) 0.81
Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients. Clin Transplant (2013) 0.81
High tumor cell expression of microRNA-21 in node positive non-small cell lung cancer predicts a favorable clinical outcome. BMC Clin Pathol (2014) 0.81
Risk factors for mortality in diabetic nephropathy patients accepted for transplantation. Transplantation (2007) 0.81
Expression of M-CSF and CSF-1R is correlated with histological grade in soft tissue tumors. Anticancer Res (2009) 0.81
Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients. Transplant Res (2012) 0.81